85 related articles for article (PubMed ID: 28412350)
1. Patient sample-oriented analysis of gene expression highlights extracellular signatures in breast cancer progression.
Hong Y; Kim N; Li C; Jeong E; Yoon S
Biochem Biophys Res Commun; 2017 May; 487(2):307-312. PubMed ID: 28412350
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix proteins as diagnostic markers of breast carcinoma.
Giussani M; Landoni E; Merlino G; Turdo F; Veneroni S; Paolini B; Cappelletti V; Miceli R; Orlandi R; Triulzi T; Tagliabue E
J Cell Physiol; 2018 Aug; 233(8):6280-6290. PubMed ID: 29521413
[TBL] [Abstract][Full Text] [Related]
3. A disease annotation study of gene signatures in a breast cancer microarray dataset.
Gypas F; Bei ES; Zervakis M; Sfakianakis S
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():5551-4. PubMed ID: 22255596
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer classification: linking molecular mechanisms to disease prognosis.
Taherian-Fard A; Srihari S; Ragan MA
Brief Bioinform; 2015 May; 16(3):461-74. PubMed ID: 24950687
[TBL] [Abstract][Full Text] [Related]
5. Generation of in situ sequencing based OncoMaps to spatially resolve gene expression profiles of diagnostic and prognostic markers in breast cancer.
Svedlund J; Strell C; Qian X; Zilkens KJC; Tobin NP; Bergh J; Sieuwerts AM; Nilsson M
EBioMedicine; 2019 Oct; 48():212-223. PubMed ID: 31526717
[TBL] [Abstract][Full Text] [Related]
6. Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging.
Yao F; Zhang C; Du W; Liu C; Xu Y
PLoS One; 2015; 10(9):e0138213. PubMed ID: 26375396
[TBL] [Abstract][Full Text] [Related]
7. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
[TBL] [Abstract][Full Text] [Related]
8. Identification of EDIL3 on extracellular vesicles involved in breast cancer cell invasion.
Lee JE; Moon PG; Cho YE; Kim YB; Kim IS; Park H; Baek MC
J Proteomics; 2016 Jan; 131():17-28. PubMed ID: 26463135
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic Subtypes of Primary Breast Cancer--Gene Expression Analysis.
Schmidt M; Thomssen C; Untch M
Oncol Res Treat; 2016; 39(3):102-10. PubMed ID: 27031354
[TBL] [Abstract][Full Text] [Related]
10. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
Hachim IY; Shams A; Lebrun JJ; Ali S
Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer.
Starmans MH; Chu KC; Haider S; Nguyen F; Seigneuric R; Magagnin MG; Koritzinsky M; Kasprzyk A; Boutros PC; Wouters BG; Lambin P
Radiother Oncol; 2012 Mar; 102(3):436-43. PubMed ID: 22356756
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix transcriptome dynamics in hepatocellular carcinoma.
Duncan MB
Matrix Biol; 2013; 32(7-8):393-8. PubMed ID: 23727079
[TBL] [Abstract][Full Text] [Related]
13. Genes and functions from breast cancer signatures.
Huang S; Murphy L; Xu W
BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
[TBL] [Abstract][Full Text] [Related]
14. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.
Waldemarson S; Kurbasic E; Krogh M; Cifani P; Berggård T; Borg Å; James P
Breast Cancer Res; 2016 Jun; 18(1):69. PubMed ID: 27357824
[TBL] [Abstract][Full Text] [Related]
16. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
17. Biomolecular features of clinical relevance in breast cancer.
Daidone MG; Paradiso A; Gion M; Harbeck N; Sweep F; Schmitt M
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S3-14. PubMed ID: 15095022
[TBL] [Abstract][Full Text] [Related]
18. A network-based approach to identify disease-associated gene modules through integrating DNA methylation and gene expression.
Zhang Y; Zhang J; Liu Z; Liu Y; Tuo S
Biochem Biophys Res Commun; 2015 Sep; 465(3):437-42. PubMed ID: 26282201
[TBL] [Abstract][Full Text] [Related]
19. The prognostic potential of alternative transcript isoforms across human tumors.
Trincado JL; Sebestyén E; Pagés A; Eyras E
Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130
[TBL] [Abstract][Full Text] [Related]
20. Effects of estrogen on global gene expression: identification of novel targets of estrogen action.
Charpentier AH; Bednarek AK; Daniel RL; Hawkins KA; Laflin KJ; Gaddis S; MacLeod MC; Aldaz CM
Cancer Res; 2000 Nov; 60(21):5977-83. PubMed ID: 11085516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
